w5- coagulation Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what triggers the activation of a hard and soft clot

A

Cleavage of fibrinogen (coagulation factor I) to fibrin (factor Ia) by thrombin results in aggregation to form a “soft clot.” Cross linking between Lys & Gln in an enzyme-mediated transamidation reaction subsequently transforms the soft clot to a “hard clot.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is Virchow’s triad

A
  • Blood flow (stasis or impaired flow) - Composition of the blood (hypercoagulability) - Changes in the vessel wall (endothelial activation or damage important for venous thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how does tx of arterial and venous thrombosis differ

A

arterial- anti-platelet venous- anti-coat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

would hyper coagulation encourage venous or arterial thrombosis

A

venous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does deoxygenation impact stasis

A

 Deoxygenation increases chance of forming blood clots  Recirculation of blood  very important for anti coag prop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does hypoxia impact venous thrombosis

A

 Cells in the vessel walls become inflamed  Bleb of microvesicles that express tissue factor  coag cascade

induces expression of P-selectin, which acts as a docking site for tissue-factor-positive microparticles, platelets, and leukocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

differentiate TPA from an anti-plasmin drug

A

o TPA- targets plasminogen o Antiplasmin- targets plasmin and prevents its conversion of fibrin to degredation products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what phase of the arterial cycle does vWVF impact and how

A

 von Willebrand factor (vWF) mediates the adhesion in response to injury by changing its MW at sites of injury recognize the change and platelets bind

deficit = bleeding disorder (most common inherited cause of bleeding disorders)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the four steps of arterial thrombus

A

adhesion

activation

secrection

aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name 3 things that are secreted during arterial thrombosis

A

Thombin (enforces activation)

ADP

thromboxin A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the targets of aspirin and clopidogrel

A

Aspirin is an irreversible cyclooxygenase-1 (COX-1) inhibitor that blocks production of TXA2 from arachidonicacid.

Clopidogrelis an ADP receptor blocker.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what phase of the arterial thombosis cycle influences microvascular constriction and immune mediators

A

secrection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what 2 phases does thrombin act on

A

activation and aggregation (clot formation by converting fibrin)

speds up the conversion of V, VIII, IX (feedback

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

outline the process of aggregation

A

Upon activation, interaction between platelets is promoted by increased surface area due to shape changes. Thrombin converts fibrinogen to fibrin. Fibrin and vWFform cross-bridges between activated platelets and stabilize the thrombus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what causes tissue factor from the extrinsic pathway to be present

what is its function

A

endothelial damage

activates XI and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the function of factor 10

what activates it

what does it interact with and how

A

function: forms complex with V to convert prothrombin to thrombin

activates: tissue factor and VII, IX and VIII

interacts with PS

X has post translational modification of carboxyl groups that allow interaction of calcium ions which bring between neg charge of PS and -carboxyglutamic acid

17
Q

which factors contain γ-carboxyglutamic acid residues and can be bound with citric chelator

A

VII, IX, X, prothrombin

18
Q

what is the target of coumadin a VIT K antagonist

A

block -carboxyglutamic acid residues post trans modifications

19
Q
A
20
Q

difference between the intrinsic and extrinsic pathway

A

Xii –> XI –> IX

indep of tissue factor

can be initiated by foreign surface such as dialysis tube or trauma/surgery and works in parallel with extrinsic

21
Q

what is the deficit in hemophillia A and B

A

A- VIII (cant activate X)

B- IX

(cant activate X)

22
Q

what activates antithombin and what does it block

A

heparin

blocks: thrombin, Xa, IXa

23
Q

what is blocked by the Tissue factor pathway inhibitor (TFPI)

A

VIIa and Xa

24
Q

what is the protein C pathways and what does it block

A

feedback loop mediated by thrombomodulin TM

TM turns on ability of thrombin to activate protein C by proteolytic cleavage.

Blocks VIII and Va

turns on TPA, blocka PAI (which inhibits TPA)

25
Q

what would a mutation in factor V result in

A

4-7x increase in risk of venous thrombosis

factor V Leiden

DO NOT TEST FOR, low penetrance

26
Q

what does pro and partial thombin time measure

A

Prothrombin time measures the extrinsic pathway + common pathway

  • dietary malabsorption*
  • sepsis*

monitor patients on oral anti-coagulants such as warfarin.

  • Partial prothrombin time* intrinsic pathway + common pathway
  • antiphospholipid antibodies*
  • hemophilia*
  • sepsis*

monitor patients on heparin

27
Q

how do neutrophils impact clotting

A

Neutrophil elastase cleaves thrombomodulinfrom endothelium, making it less effective in activating protein C

Bound, activated leukocytes sequester platelets which trigger the clotting cascade

Monocyte activation leads to tissue factor expression on their surface and trigger clotting cascade

28
Q

what are 2 ways to break down a clot

A

TPA and Streptokinase

convertes plasminogen to plasmin